Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.

Chiu H, Trisal P, Bjorklund C, Carrancio S, Toraño EG, Guarinos C, Papazoglou D, Hagner PR, Beldi-Ferchiou A, Tarte K, Delfau-Larue MH, Morschhauser F, Ramsay AG, Gandhi AK.

Br J Haematol. 2019 Apr;185(2):240-253. doi: 10.1111/bjh.15797. Epub 2019 Feb 14.

2.

Combination targeted therapy in chronic lymphocytic leukaemia - can pre-clinical studies translate to the clinic?

Ioannou N, Ramsay AG.

Br J Haematol. 2018 Aug;182(3):315-316. doi: 10.1111/bjh.15279. Epub 2018 May 16. No abstract available.

PMID:
29767410
3.

miR-181c-BRK1 axis plays a key role in actin cytoskeleton-dependent T cell function.

Lim SP, Ioannou N, Ramsay AG, Darling D, Gäken J, Mufti GJ.

J Leukoc Biol. 2018 May;103(5):855-866. doi: 10.1002/JLB.1A0817-325RR. Epub 2018 Apr 14.

PMID:
29656550
4.

Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicity.

Hagner PR, Chiu H, Ortiz M, Apollonio B, Wang M, Couto S, Waldman MF, Flynt E, Ramsay AG, Trotter M, Gandhi AK, Chopra R, Thakurta A.

Br J Haematol. 2017 Nov;179(3):399-409. doi: 10.1111/bjh.14866. Epub 2017 Aug 2.

PMID:
28771673
5.

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.

Pasikowska M, Walsby E, Apollonio B, Cuthill K, Phillips E, Coulter E, Longhi MS, Ma Y, Yallop D, Barber LD, Patten P, Fegan C, Ramsay AG, Pepper C, Devereux S, Buggins AG.

Blood. 2016 Jul 28;128(4):563-73. doi: 10.1182/blood-2016-01-683128. Epub 2016 Jun 1.

PMID:
27252234
6.

Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.

Smallwood DT, Apollonio B, Willimott S, Lezina L, Alharthi A, Ambrose AR, De Rossi G, Ramsay AG, Wagner SD.

Blood. 2016 Jul 28;128(4):542-52. doi: 10.1182/blood-2015-11-682377. Epub 2016 Apr 26.

PMID:
27118451
7.

Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.

Boissard F, Laurent C, Ramsay AG, Quillet-Mary A, Fournié JJ, Poupot M, Ysebaert L.

Blood Cancer J. 2016 Jan 15;6:e381. doi: 10.1038/bcj.2015.108. No abstract available.

8.

Subclonal heterogeneity in chronic lymphocytic leukaemia: revealing the importance of the lymphoid tumour microenvironment.

Apollonio B, Ramsay AG.

Br J Haematol. 2016 Jan;172(1):7-8. doi: 10.1111/bjh.13856. Epub 2015 Nov 24. No abstract available.

PMID:
26597651
9.

Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.

Nicholas NS, Apollonio B, Ramsay AG.

Biochim Biophys Acta. 2016 Mar;1863(3):471-482. doi: 10.1016/j.bbamcr.2015.11.003. Epub 2015 Nov 7. Review.

10.

Exosomes and CAFs: partners in crime.

Apollonio B, Ramsay AG.

Blood. 2015 Aug 27;126(9):1053-5. doi: 10.1182/blood-2015-07-655233.

PMID:
26316614
11.

Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.

Nakagawa R, Vukovic M, Tarafdar A, Cosimo E, Dunn K, McCaig AM, Holroyd A, McClanahan F, Ramsay AG, Gribben JG, Michie AM.

Haematologica. 2015 Apr;100(4):499-510. doi: 10.3324/haematol.2014.112276. Epub 2015 Jan 23.

12.

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

Kater AP, Tonino SH, Egle A, Ramsay AG.

Blood. 2014 Oct 2;124(14):2184-9. doi: 10.1182/blood-2014-05-578286. Epub 2014 Aug 26. Review.

PMID:
25161268
13.

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.

Riches JC, O'Donovan CJ, Kingdon SJ, McClanahan F, Clear AJ, Neuberg DS, Werner L, Croce CM, Ramsay AG, Rassenti LZ, Kipps TJ, Gribben JG.

Blood. 2014 Jun 26;123(26):4101-10. doi: 10.1182/blood-2014-01-552307. Epub 2014 May 14.

14.

Identifying CLL antigens for future combinational therapy.

Ramsay AG.

Blood. 2013 Nov 7;122(19):3241-2. doi: 10.1182/blood-2013-09-526376. No abstract available.

PMID:
24203924
15.

Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

Ene-Obong A, Clear AJ, Watt J, Wang J, Fatah R, Riches JC, Marshall JF, Chin-Aleong J, Chelala C, Gribben JG, Ramsay AG, Kocher HM.

Gastroenterology. 2013 Nov;145(5):1121-32. doi: 10.1053/j.gastro.2013.07.025. Epub 2013 Jul 25.

16.

Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.

Kiaii S, Clear AJ, Ramsay AG, Davies D, Sangaralingam A, Lee A, Calaminici M, Neuberg DS, Gribben JG.

J Clin Oncol. 2013 Jul 20;31(21):2654-61. doi: 10.1200/JCO.2012.44.2137. Epub 2013 Jun 17.

17.

Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.

Ramsay AG.

Br J Haematol. 2013 Aug;162(3):313-25. doi: 10.1111/bjh.12380. Epub 2013 May 21. Review.

PMID:
23691926
18.

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).

Shanafelt TD, Ramsay AG, Zent CS, Leis JF, Tun HW, Call TG, LaPlant B, Bowen D, Pettinger A, Jelinek DF, Hanson CA, Kay NE.

Blood. 2013 May 16;121(20):4137-41. doi: 10.1182/blood-2012-12-470005. Epub 2013 Mar 14.

PMID:
23493782
19.

Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide.

Ramsay AG, Evans R, Kiaii S, Svensson L, Hogg N, Gribben JG.

Blood. 2013 Apr 4;121(14):2704-14. doi: 10.1182/blood-2012-08-448332. Epub 2013 Jan 16.

20.

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.

Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, Ramsay AG, Gribben JG.

Blood. 2013 Feb 28;121(9):1612-21. doi: 10.1182/blood-2012-09-457531. Epub 2012 Dec 17.

21.

The end of an era. 1952.

Ramsay AG.

Public Health Nurs. 2012 Jul-Aug;29(4):380-3. doi: 10.1111/j.1525-1446.2012.01020.x.

PMID:
22765250
22.

Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy.

Riches JC, Ramsay AG, Gribben JG.

Curr Pharm Des. 2012;18(23):3389-98. Review.

PMID:
22591385
23.
24.

Immune reconstitution in chronic lymphocytic leukemia.

Riches JC, Ramsay AG, Gribben JG.

Curr Hematol Malig Rep. 2012 Mar;7(1):13-20. doi: 10.1007/s11899-011-0106-x. Review.

25.

The kiss of death in FL.

Ramsay AG, Gribben JG.

Blood. 2011 Nov 17;118(20):5365-6. doi: 10.1182/blood-2011-09-377283.

PMID:
22096253
26.

Chronic lymphocytic leukemia: an update on biology and treatment.

Riches JC, Ramsay AG, Gribben JG.

Curr Oncol Rep. 2011 Oct;13(5):379-85. doi: 10.1007/s11912-011-0188-6.

PMID:
21773694
27.

Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.

Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, Hart IR, Marshall JF.

Oncogene. 2011 Mar 24;30(12):1422-35. doi: 10.1038/onc.2010.535. Epub 2010 Dec 6.

PMID:
21132011
28.

T-cell function in chronic lymphocytic leukaemia.

Riches JC, Ramsay AG, Gribben JG.

Semin Cancer Biol. 2010 Dec;20(6):431-8. doi: 10.1016/j.semcancer.2010.09.006. Epub 2010 Oct 27. Review.

PMID:
20920582
29.

Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and starch.

Scott KP, Martin JC, Chassard C, Clerget M, Potrykus J, Campbell G, Mayer CD, Young P, Rucklidge G, Ramsay AG, Flint HJ.

Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4672-9. doi: 10.1073/pnas.1000091107. Epub 2010 Aug 2.

30.

Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

Xing D, Ramsay AG, Gribben JG, Decker WK, Burks JK, Munsell M, Li S, Robinson SN, Yang H, Steiner D, Shah N, McMannis JD, Champlin RE, Hosing C, Zweidler-McKay PA, Shpall EJ, Bollard CM.

J Immunother. 2010 Sep;33(7):684-96. doi: 10.1097/CJI.0b013e3181e475e9.

31.

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Clear AJ, Lee AM, Calaminici M, Ramsay AG, Morris KJ, Hallam S, Kelly G, Macdougall F, Lister TA, Gribben JG.

Blood. 2010 Jun 17;115(24):5053-6. doi: 10.1182/blood-2009-11-253260. Epub 2010 Apr 7.

32.

The 3 Rs in CLL immune dysfunction.

Ramsay AG, Gribben JG.

Blood. 2010 Apr 1;115(13):2563-4. doi: 10.1182/blood-2009-12-256909. No abstract available.

PMID:
20360474
33.

Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.

Ramsay AG, Clear AJ, Kelly G, Fatah R, Matthews J, Macdougall F, Lister TA, Lee AM, Calaminici M, Gribben JG.

Blood. 2009 Nov 19;114(21):4713-20. doi: 10.1182/blood-2009-04-217687. Epub 2009 Sep 28.

34.

Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.

Ramsay AG, Gribben JG.

Haematologica. 2009 Sep;94(9):1198-202. doi: 10.3324/haematol.2009.009274. Review. No abstract available.

35.

Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.

Le Dieu R, Taussig DC, Ramsay AG, Mitter R, Miraki-Moud F, Fatah R, Lee AM, Lister TA, Gribben JG.

Blood. 2009 Oct 29;114(18):3909-16. doi: 10.1182/blood-2009-02-206946. Epub 2009 Aug 26.

36.

E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.

Gorgun G, Ramsay AG, Holderried TA, Zahrieh D, Le Dieu R, Liu F, Quackenbush J, Croce CM, Gribben JG.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6250-5. doi: 10.1073/pnas.0901166106. Epub 2009 Mar 30.

37.

Vaccine therapy and chronic lymphocytic leukaemia.

Ramsay AG, Gribben JG.

Best Pract Res Clin Haematol. 2008 Sep;21(3):421-36. doi: 10.1016/j.beha.2008.07.005.

PMID:
18790447
38.

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.

Ramsay AG, Johnson AJ, Lee AM, Gorgün G, Le Dieu R, Blum W, Byrd JC, Gribben JG.

J Clin Invest. 2008 Jul;118(7):2427-37. doi: 10.1172/JCI35017.

39.

Integrin trafficking and its role in cancer metastasis.

Ramsay AG, Marshall JF, Hart IR.

Cancer Metastasis Rev. 2007 Dec;26(3-4):567-78. Review.

PMID:
17786537
40.

HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6.

Ramsay AG, Keppler MD, Jazayeri M, Thomas GJ, Parsons M, Violette S, Weinreb P, Hart IR, Marshall JF.

Cancer Res. 2007 Jun 1;67(11):5275-84.

41.

Cell-associated alpha-amylases of butyrate-producing Firmicute bacteria from the human colon.

Ramsay AG, Scott KP, Martin JC, Rincon MT, Flint HJ.

Microbiology. 2006 Nov;152(Pt 11):3281-90.

PMID:
17074899
42.

Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system.

Duncan SH, Scott KP, Ramsay AG, Harmsen HJ, Welling GW, Stewart CS, Flint HJ.

Appl Environ Microbiol. 2003 Feb;69(2):1136-42.

43.

Acute tubulo-interstitial nephritis from candida albicans with oliguric renal failure.

Ramsay AG, Olesnicky L, Pirani CL.

Clin Nephrol. 1985 Dec;24(6):310-4.

PMID:
4075600
44.

Oxalate removal by hemodialysis in end-stage renal disease.

Ramsay AG, Reed RG.

Am J Kidney Dis. 1984 Sep;4(2):123-7.

PMID:
6475942
45.

Renal functional recovery 47 days after renal artery occlusion.

Ramsay AG, D'Agati V, Dietz PA, Svahn DS, Pirani CL.

Am J Nephrol. 1983 Nov-Dec;3(6):325-8.

PMID:
6650591
46.

Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease.

Hoffman GS, Schumacher HR, Paul H, Cherian V, Reed R, Ramsay AG, Franck WA.

Ann Intern Med. 1982 Jul;97(1):36-42.

PMID:
7092004
47.

Membrane potentials, resistances, and conductances of toad bladder during Na+ - H+ transport and H+ transport.

Ramsay AG.

Proc Soc Exp Biol Med. 1982 May;170(1):94-102. No abstract available.

PMID:
6281798
48.

Influence of mucosal sodium concentration on electrical resistances and potentials of toad bladder.

Ramsay AG, Gallagher DL.

Proc Soc Exp Biol Med. 1980 May;164(1):57-62. No abstract available.

PMID:
6769130
49.

Barium inhibition of sodium ion transport in toad bladder.

Ramsay AG, Gallagher DL, Shoemaker RL, Sachs G.

Biochim Biophys Acta. 1976 Jul 1;436(3):617-27.

PMID:
821526
50.

The effect of methyl acetylsalicylate on renal tubular ionic reabsorption.

Ramsay AG, Elliott HC, Haynes AM.

Proc Soc Exp Biol Med. 1969 Oct;132(1):307-13. No abstract available.

PMID:
5344852

Supplemental Content

Loading ...
Support Center